LAMTOR2 Antibody - Primary antibody, specific to LAMTOR2, Rabbit IgG

Cat. No.: Ab112761
DISPONIBLE À COMMANDE
QUALITÉ & PURETÉ ExactAb™ ? ExactAb™ — Aladdin's antibody line emphasizing precision and validated quality. Use for reliable, specificity-validated antibody applications. Validated ? Validated grade — performance confirmed in defined applications before release. Use when you want documented assurance the reagent works as stated. 1.0 mg/mL
Application
WB
Host species
Rabbit
Reactive species
Human, Mouse
Isotype
Rabbit IgG
Conjugation
Unconjugated
★
Taille
USA
Allemagne (EU)*
Prix
Qté
10μl
Ab112761-10μl
1 En stock
—
99,90$US
50μl
Ab112761-50μl
1 En stock
—
259,90$US
100μl
Ab112761-100μl
Fabrication sur commande aux États-Unis · 2–4 semaines ·
—
419,90$US
1ml
Ab112761-1ml
Fabrication sur commande aux États-Unis · 2–4 semaines ·
—
2 799,90$US
Enter a quantity for the sizes you want to add.

Vue d’ensemble

Rabbit anti Human LAMTOR2 Antibody, Polyclonal, could be used for WB and so on.
Application:
WB: 1/500-1/2000
Protein Function
As part of the Ragulator complex it is involved in amino acid sensing and activation of mTORC1, a signaling complex promoting cell growth in response to growth factors, energy levels, and amino acids. Activated by amino acids through a mechanism involving the lysosomal V-ATPase, the Ragulator functions as a guanine nucleotide exchange factor activating the small GTPases Rag. Activated Ragulator and Rag GTPases function as a scaffold recruiting mTORC1 to lysosomes where it is in turn activated. Adapter protein that enhances the efficiency of the MAP kinase cascade facilitating the activation of MAPK2.

Spécifications

Product Name
LAMTOR2 Antibody - Primary antibody, specific to LAMTOR2, Rabbit IgG
Synonymes
Endosomal adaptor protein p14 antibody|LAMTOR2 antibody|Late endosomal/lysosomal adaptor and MAPK and MTOR activator 2 antibody|Late endosomal/lysosomal Mp1 interacting protein antibody|Late endosomal/lysosomal Mp1-interacting protein antibody|Mitogen-activated protein-binding protein-interacting protein antibody|p14 antibody|Ragulator complex protein LAMTOR2 antibody|Ragulator2 antibody|Roadblock domain containing 3 antibody|Roadblock domain-containing protein 3 antibody|ROBLD 3 antibody|robld3 antibody|RP11 336K24.9 antibody|LAMTOR2|p14|ENDAP|ROBLD3|MAPBPIP|MAPKSP1AP|Ragulator2
Spécifications et pureté
ExactAb™, Validated, 1.0 mg/mL
Espèce hôte
Rabbit
Spécificité
LAMTOR2
Immunogène
A synthetic peptide derived from human LAMTOR2 (AA 10-90)
Contrôle positif
WB: U-2 OS, Hep G2, LNCaP, MCF7 and Raji cell lysates.
Conjugation
Unconjugated
Grade
ExactAb™, Validated
Isotype
Rabbit IgG
SDS-PAGE
150 kDa
Méthode de purification
Immunogen affinity purified
Concentration
1.0 mg/mL
Product Line
Produits biologiques
Stockage et expédition
Forme
Liquid
Conditions de stockage de stockage
Store at -20°C,Avoid repeated freezing and thawing
Expédié en
Ice chest + Ice pads
Stabilité et stockage
Store at -20°C long term (12 months). Upon receipt, it is recommended to aliquot. Avoid freeze/thaw cycle.
Images

LAMTOR2 Antibody (Ab112761) - Western Blot
All lanes: LAMTOR2 Antibody (Ab112761) at 1/1000 dilution
Samples: Lysates at 20 µg per lane
Secondary: Goat Anti-Rabbit IgG H&L (HRP) (Ab170144) at 1/20000 dilution

Predicted band size: 13 kDa
Observed band size: 12 kDa
Exposure time: 1.9 s

Application
Application
Dilution info
WB

1/500-1/2000

Données avancées

Cibles associées (humaines)
LAMTOR2 Tbio Ragulator complex protein LAMTOR2 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
Certificats (CoA, COO, BSE/TSE et tableau d'analyse)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

2 results found

Lot NumberCertificate TypeDateArticle
ZJ24F0910756ZJ24F0910756Certificate of AnalysisApr 07, 2026 Ab112761
ZJ24F0910757ZJ24F0910757Certificate of AnalysisApr 07, 2026 Ab112761
FAQ et articles
Calculateurs de solution
Avis

Avis des clients

Application Protocols

Tested applications, recommended working dilutions, positive control samples, antigen retrieval conditions, and detection systems are Not specified for this item; refer to the CoA/Spec Sheet.

General note: Establish assay conditions empirically and include appropriate positive/negative controls. See “Reaction & Applications” and “Reaction Conditions” for literature-based starting guidance.

Biological Roles

LAMTOR2 (literature; target biology overview) is a small lysosome-associated adaptor protein, also known as p14, and is an integral component of the Ragulator (LAMTOR) complex on late endosomes/lysosomes.

  • Complex assembly and localization: LAMTOR2 pairs with LAMTOR3 (p18) and other LAMTOR subunits to anchor signaling modules to the lysosomal membrane, coordinating nutrient sensing and trafficking.
  • mTORC1 activation: The Ragulator complex functions as a guanine nucleotide exchange factor (GEF) for Rag GTPases. By recruiting and activating mTORC1 on lysosomes in response to amino acids, LAMTOR2 is pivotal in regulating protein synthesis, autophagy, and cell growth.
  • MAPK/ERK pathway: Historically identified as a scaffold for MEK1/2–ERK1/2 on endosomal membranes, facilitating spatial organization of MAPK signaling following receptor activation.
  • Endolysosomal dynamics: Contributes to endosome maturation and cargo sorting. Disruption affects lysosomal positioning and signaling competence.
  • Expression and conservation: Broadly conserved across metazoans; expression varies by tissue and cellular metabolic state.

Research implications (general): Antibodies against LAMTOR2 enable interrogation of nutrient signaling, lysosomal biology, and stress responses. They support studies of mTORC1 modulation, autophagy regulation, and spatiotemporal MAPK signaling. Item-specific epitope, species reactivity, and validation data are Not specified for this item; consult the CoA/Spec Sheet to align your experimental design with verified conditions.

Buffer Applications

This product is an antibody reagent and does not function as a buffering agent. For experimental use, antibodies are typically formulated or diluted in standard biological buffers (e.g., PBS, TBS, or assay-specific blocking buffers). Item-specific buffer composition and recommended diluents are Not specified for this item; refer to the CoA/Spec Sheet.

Green Alternatives

While antibodies are aqueous biological reagents and not classical solvents/reagents with direct green chemistry substitutions, sustainability can be improved through handling and workflow choices (general guidance):

  • Buffer choices: Prefer phosphate- or HEPES-based buffers prepared with ultrapure water; avoid volatile organic solvents. Where preservatives are needed, select minimal effective concentrations and assess azide-free alternatives if compatible.
  • Minimize waste: Use small‑format aliquots to reduce freeze–thaw cycles and product loss; scale experiments to reduce consumable usage.
  • Energy efficiency: Store at recommended temperatures and avoid unnecessary ultra‑low storage if stability allows per CoA/Spec Sheet. Consolidate freezer space; use energy‑efficient freezers.
  • Reusability: Where compatible, use rechargeable protein A/G columns for IP workflows rather than single‑use beads to reduce plastic waste.
  • Shipping: Product is shipped on cold packs as specified; coordinate deliveries to minimize re-shipments and reduce packaging waste.

Tradeoffs:

  • Preservative-free or lyophilized formats can lower hazardous waste (e.g., azide), but may require more stringent aseptic technique and can shorten open-vial stability.
  • Glycerol-containing formulations reduce freezing needs (–20°C storage with 50% glycerol), but increase carbon footprint in transport due to mass/volume (applicability Not specified for this item).
Pharmaceutical Uses

This reagent is supplied for research use only (RUO) and is not intended for diagnostic, therapeutic, or human/animal administration.

In pharmaceutical R&D settings (general, non-clinical):

  • Anti‑LAMTOR2 antibodies may be used as analytical tools for target validation, pathway mapping (mTORC1/MAPK), and biomarker discovery in preclinical samples.
  • They can support QC analytics (e.g., Western blotting of pathway markers in cell-line qualification) and mechanism-of-action studies in discovery biology.

No pharmacopeial status, excipient role, or clinical manufacturing utility is claimed or provided for this product. Any GMP or GLP applicability, if required, must be established independently; item-specific certifications are Not specified for this item.

Physical Properties

This product is an antibody reagent; small-molecule physical constants (bp/mp) are not applicable.

Item-specific properties:

  • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
  • Concentration and formulation buffer: Not specified for this item; refer to CoA/Spec Sheet.
  • Purity/aggregation profile: Not specified for this item; refer to CoA/Spec Sheet.

Literature/general values for typical IgG antibodies (for context only; not item specifications):

  • Approx. molecular mass (monomeric IgG): ~150 kDa (literature)
  • Isoelectric point (IgG): typically pI ~6–9 depending on isotype and glycosylation (literature)
  • Solubility: Readily soluble in aqueous buffers (PBS, Tris) across physiological pH; stability influenced by ionic strength, pH, excipients (literature)
  • Storage form impacts: Liquid formulations may include protein stabilizers (e.g., BSA), sugars (e.g., trehalose), and antimicrobial preservatives (e.g., sodium azide); lyophilized formats reconstitute in sterile buffer (literature)

Refractive index, logP, pKa, density: not meaningful/typically reported for antibody preparations. For precise lot-specific details (buffer composition, concentration, stabilizers), consult the product CoA/Spec Sheet.

Quality and Grades
  • Grade/Purity (from Product Data): ExactAb™, Validated.

    • ExactAb™ (general description): signifies a high-quality, application-driven antibody line emphasizing stringent characterization, consistency, and fit-for-purpose validation in common immunoassays. Specific validation datasets and criteria vary by product and lot; consult CoA/Spec Sheet for this item.
    • Validated: Indicates that performance has been confirmed against the intended antigen in one or more laboratory applications. The precise applications, sample types, and validation images/metrics are Not specified for this item; refer to CoA/Spec Sheet.
  • What this means in practice (general guidance for professional users):

    • Expect defined identity (reactivity to LAMTOR2), traceability to lot, and quality controls such as immunoreactivity checks and purity/aggregation assessment by SDS-PAGE/SEC (item-specific data Not specified for this item).
    • If stabilizers or preservatives are used, they support shelf life and freeze–thaw robustness; their presence/levels are Not specified for this item.
  • Documentation and compliance:

    • CoA/Spec Sheet provides lot-specific concentration, buffer composition, recommended storage, and validated applications/conditions.
    • This reagent is supplied strictly for research use only (RUO); not for diagnostic or therapeutic use.
Reaction and Applications

As an anti‑LAMTOR2 research antibody, the primary use is in immunodetection and affinity-based workflows rather than chemical synthesis.

Typical laboratory applications (literature/general; item-specific validation Not specified for this item):

  • Western blot (WB): Detects denatured LAMTOR2 in cell/tissue lysates. Key considerations include antigen size, transfer efficiency, and optimizing blocking to reduce background.
  • Immunofluorescence (IF/ICC): Visualizes subcellular localization (LAMTOR2 is lysosome-associated). Permeabilization (e.g., saponin, Triton X‑100) and fixation method (PFA vs. methanol) influence epitope accessibility.
  • Immunohistochemistry (IHC): Detection in tissue sections; optimize antigen retrieval (heat-induced vs. enzymatic) based on epitope stability.
  • Immunoprecipitation (IP/Co‑IP): Captures LAMTOR2 and associated Ragulator/mTOR pathway components for interaction studies; use gentle lysis buffers to preserve complexes.
  • Flow cytometry (less common for intracellular targets): Possible with permeabilization; conjugated formats may be used if available.

Practical tips (general):

  • Validate specificity with siRNA/CRISPR knockdown/knockout controls or peptide competition when feasible.
  • Include positive controls (lysates from cells with robust lysosomal signaling) and negative controls (isotype control, no-primary).
  • Titrate antibody to determine optimal working dilution; lot-specific recommendations are Not specified for this item and should be established empirically or obtained from the CoA/Spec Sheet.
Reaction Conditions

Classical chemical reaction conditions are not applicable to antibody use. For immunochemical workflows (general guidance; item-specific protocols Not specified for this item):

  • Western Blot: Common primary antibody incubations at 4°C overnight or 1–2 h at room temperature in blocking buffer; secondary incubations 1 h at room temperature. Wash with TBS‑T or PBS‑T.
  • IF/ICC: Primary incubation 1–16 h depending on epitope accessibility; permeabilization with 0.1–0.5% detergents as appropriate. Maintain isotonic buffers to preserve cellular morphology.
  • IHC: Optimize antigen retrieval (pH 6 citrate or pH 9 Tris‑EDTA, heat-induced) per tissue/epitope; primary incubation often overnight at 4°C.
  • IP/Co‑IP: 1–4 h binding at 4°C with gentle rotation; use low‑stringency lysis for complex preservation or high‑stringency for specificity.

These are literature-based starting points only. Obtain lot-specific recommended dilutions/conditions from the CoA/Spec Sheet and validate empirically.

Safety and Handling
  • GHS classification / Signal word / H‑statements / Pictograms: Not specified for this item; refer to SDS.
  • General laboratory safety (antibody proteins; literature/best practice):
    • Handle using standard biosafety level 1/2 precautions depending on sample origin and any added preservatives (e.g., sodium azide). Avoid ingestion, inhalation of aerosols, and contact with skin/eyes.
    • Wear appropriate PPE: lab coat, gloves, and safety glasses. Work in a clean area to prevent contamination.
    • If the formulation contains sodium azide (not specified), avoid contact with acids and copper/lead plumbing due to potential formation of metal azides; flush drains with copious water.
  • First aid (general): Rinse affected skin/eyes with water for 15 minutes; seek medical attention if irritation persists. If inhaled, move to fresh air. If swallowed, rinse mouth and seek medical advice. Defer to SDS for authoritative guidance.
  • Incompatibilities (general): Strong acids/bases and oxidants may denature proteins; repeated freeze–thaw cycles degrade antibodies—see Storage section.
  • Spill/cleanup: Absorb liquid with inert material; disinfect surfaces. Dispose according to institutional and local regulations for proteinaceous/biological laboratory reagents.

Always consult the product-specific SDS and institutional biosafety procedures before use.

Solvent Selection

This product is an aqueous antibody preparation or lyophilized protein reagent; organic solvent selection is not typically applicable.

  • For routine use, antibodies are handled in physiological buffers (e.g., PBS, Tris-buffered saline) with optional additives (e.g., glycerol, sugars, carrier proteins) to enhance stability (literature/general). Item-specific buffer composition is Not specified for this item; refer to CoA/Spec Sheet.
  • If conjugation or specialized formulations are planned, select buffers free of amines, thiols, or azides as required by the chemistry (e.g., NHS-ester labeling requires amine-free buffers; maleimide labeling requires free sulfhydryls).
Storage and Reconstitution
  • Storage conditions (from Product Data): Store at −20°C. Avoid repeated freezing and thawing.
  • Shipping: Shipped in an ice chest with ice pads (from Product Data) to maintain cold-chain integrity.

Best practices (general; defer to CoA/Spec Sheet for item-specifics):

  • Upon receipt, inspect packaging temperature. Centrifuge briefly to collect contents.
  • If the antibody is supplied in liquid form, aliquot into single‑use volumes to prevent multiple freeze–thaw cycles. For many antibody formulations, storage at −20°C or −80°C is typical; short-term (days to 1–2 weeks) at 2–8°C may be acceptable depending on preservatives (not specified for this item).
  • If lyophilized, reconstitute with sterile, filtered buffer (e.g., PBS or manufacturer-recommended diluent) to the desired concentration. Mix gently; avoid foaming. Allow complete dissolution on ice.
  • Protect from microbial contamination; use sterile technique. Avoid prolonged exposure to ambient temperatures.
  • Do not store in frost-free freezers that cycle temperatures. Document aliquot IDs and freeze dates for traceability.

For formulation details (buffer composition, stabilizers such as glycerol/BSA/sugars) and any special storage notes, consult the product CoA/Spec Sheet.

Structure and Identity

LAMTOR2 Antibody (SKU: Ab112761) is an affinity reagent directed against the lysosomal adaptor protein LAMTOR2 (also known in the literature as p14), supplied for research use.

  • Reagent type: Antibody (protein-based affinity reagent) targeting LAMTOR2
  • Intended target: LAMTOR2 protein (lysosomal adaptor and MAPK/mTOR pathway component; literature)
  • Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.
  • SMILES / InChI / InChIKey: Not applicable to antibodies; not provided for this item.
  • Structural features (general, literature):
    • Typical research antibodies are immunoglobulins (e.g., IgG) composed of two heavy and two light chains with disulfide linkages.
    • Domain architecture includes variable (antigen-binding) and constant regions; glycosylation may be present depending on host and expression system.

Verbal 2D description (general): Y‑shaped heterotetrameric protein where the variable domains at the tips of the Fab arms confer specificity to an epitope on LAMTOR2; the Fc stem provides effector functions and enables purification/capture (literature). Item-specific isotype/clone/sequence are Not specified for this item; refer to CoA/Spec Sheet.

Synthetic Utility

Not typically applicable. As a biological affinity reagent, this antibody is not used as a chemical building block or synthetic reagent. For research needs, see the “Reaction & Applications” section for immunoassay and affinity-capture use cases relevant to LAMTOR2 biology.

Target Specificity
  • Target name, epitope, species reactivity, clone, isotype, and cross-reactivity: Not specified for this item; refer to CoA/Spec Sheet.

Note: LAMTOR2 (p14) is a lysosomal adaptor in the Ragulator complex (literature). However, item-specific epitope mapping and species coverage must be confirmed from the provided documentation.

Foire aux questions

What does ExactAb? mean?
ExactAb? indicates the product has been validated for use in rigorous antibody validation workflows. Validation may include positive/negative control samples, signal-to-noise testing, and protocol-specific QC. Lot-specific test data is published on the Certificate of Analysis where available.
What does Validated mean?
Validated indicates the product has been validated for use in rigorous antibody validation workflows. Validation may include positive/negative control samples, signal-to-noise testing, and protocol-specific QC. Lot-specific test data is published on the Certificate of Analysis where available.
How should this product be stored?
Store at ?20 °C. Avoid repeated freeze–thaw cycles. Aliquot into single-use volumes before freezing.
How is this product shipped?
This product ships in an insulated container with ice pads. Unpack on arrival and transfer it to the storage condition stated above.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.
Which species reactivity has this antibody been validated against?
Validated reactivity is listed on the PDP and on each lot's datasheet. We validate against the most commonly tested species for the target (LAMTOR2 Antibody); cross-reactivity in untested species may exist but is not guaranteed. Contact technical support for specific species inquiries.

Besoin d'aide pour choisir la qualité ?

Notre guide de sélection des qualités couvre la pureté, le statut du stabilisant et l'adéquation à l'application pour toutes les variantes de notre catalogue.

Voir le guide des qualités Validated → Voir le guide des qualités ExactAb™ →

Produits apparentés

Goat Anti-Rabbit IgG H&L Antibody - Secondary antibody, for ELISA,LF,GICA various applications, from Rabbit, generated in Goat
Goat Anti-Rabbit IgG H&L (AF594) - Secondary antibody, IgG
Goat Anti-Rabbit IgG H&L (Biotin) - Secondary antibody, IgG
Goat Anti-Rabbit IgG H&L (AF488) - Secondary antibody, IgG
Goat Anti-Rabbit IgG H&L (AF405) - Secondary antibody, IgG
Donkey Anti-Rabbit IgG H&L (AF647) - Secondary antibody, specific to , IgG
Donkey Anti-Rabbit IgG H&L (Biotin) - Secondary antibody, IgG
Goat Anti-Rabbit IgG H&L (HRP) - Secondary antibody
Goat Anti-Rabbit IgG H&L Antibody - Secondary antibody, Goat IgG
Goat Anti-Rabbit IgG H&L (Biotin) - Secondary antibody
Goat Anti-Rabbit IgG H&L (Cy5) - Secondary antibody
Goat Anti-Rabbit IgG H&L (FITC) - Secondary antibody
Goat Anti-Rabbit IgG H&L (TRITC) - Secondary antibody
Goat Anti-Rabbit IgG H&L (Biotin) - Secondary antibody, Goat IgG
Goat Anti-Rabbit IgG H&L (HRP) - Secondary antibody, Goat IgG
Goat Anti-Rabbit IgG H&L (Cy5) - Secondary antibody, Goat IgG
Goat Anti-Rabbit IgG H&L (TRITC) - Secondary antibody, Goat IgG
Goat Anti-Rabbit IgG H&L (FITC) - Secondary antibody, Goat IgG
Goat Anti-Rabbit IgG H&L (PE) - Secondary antibody, Goat IgG
Goat Anti-Rabbit IgG H&L (APC) - Secondary antibody, Goat IgG
Goat Anti-Rabbit IgG H&L (AF647) - Secondary antibody, Goat IgG
Goat Anti-Rabbit IgG H&L (AF405) - Secondary antibody, Goat IgG
Goat Anti-Rabbit IgG H&L (AF555) - Secondary antibody, Goat IgG
Goat Anti-Rabbit IgG H&L (AF546) - Secondary antibody, specific to Rabbit IgG
Goat Anti-Rabbit IgG H&L (AF700) - Secondary antibody, specific to Rabbit IgG
Goat Anti-Rabbit IgG H&L (AF488) - Secondary antibody
Goat Anti-Rabbit IgG H&L (AF647) (Ready to use) - Secondary antibody, specific to Rabbit IgG

Souhaitez-vous que nous vous envoyions un message lorsque des réductions seront disponibles?

Me rappeler plus tard

Merci ! Veuillez vérifier votre boîte de réception e-mail pour confirmer.

Oups ! Les notifications sont désactivées.